Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2606 USD | +2.60% |
|
-12.84% | -97.63% |
06-24 | CERo Therapeutics Holdings, Inc.(NasdaqGM:CERO) added to S&P TMI Index | CI |
06-06 | CERo Therapeutics, Inc. Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236 | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
3.83M | - | - | - | - | - | |
121B | ||||||
110B | ||||||
25.98B | - | |||||
19.27B | - | |||||
15.99B |